MetroCreative Inflammatory bowel disease (IBD) affects between 2.4 and 3.1 million people across the United States, according ...

For many people with Crohn’s disease, reaching remission—when inflammation is no longer detectable—seems like a major victory ...

Lutikizumab is under clinical development by AbbVie and currently in Phase II for Crohn's Disease (Regional Enteritis).

Mesenchymal Stromal Cell Therapy is under clinical development by Orbsen Therapeutics and currently in Phase II for Crohn's Disease (Regional Enteritis).

Steqeyma is approved for adult and pediatric patients with plaque psoriasis and active psoriatic arthritis as well as adults ...

A Risky Business: Why Do Some Parkinson's Disease Treatments Affect Decision Making? Sep. 24, 2024 — Parkinson's disease, a debilitating nervous system disorder, is treated with medications that ...

Intestines suffer a lot of wear and tear in their daily service to digestion, requiring constant renewal of their lining.

I saw your T-shirt,’ she said, pointing at the Crohn’s & Colitis UK logo emblazoned across my chest. ‘I have Crohn’s. I’ve ...

Teva Pharmaceutical Industries continues to impress investors with strong sales growth and promising development. Click here ...

A specific class of anti-inflammatory drugs can help children avoid a debilitating complication of Crohn's disease, a new ...

A specific class of anti-inflammatory drugs can help children avoid a debilitating complication of Crohn’s disease.A new ...